Literature DB >> 1705666

ELAM-1 is an adhesion molecule for skin-homing T cells.

L J Picker1, T K Kishimoto, C W Smith, R A Warnock, E C Butcher.   

Abstract

Endothelial cell leukocyte adhesion molecule-1 (ELAM-1) has been described as an inducible endothelial cell-adhesion molecule for neutrophils, and is believed to have a key role in the extravasation of these cells at sites of acute inflammation. Here we report that ELAM-1-transfected COS cells also bind a unique skin-associated subset of circulating memory T cells defined by the expression of the cutaneous lymphocyte-associated antigen. T cells expressing this antigen bind at least as well as neutrophils to expressed ELAM-1, whereas other lymphocytes in the peripheral blood bind poorly, or not at all. Immunohistological survey of chronically inflamed tissue specimens revealed that vascular expression of ELAM-1 occurs at cutaneous sites in preference to noncutaneous sites. We conclude that at sites of chronic inflammation, ELAM-1 may function as a skin vascular addressin, a tissue-selective endothelial cell-adhesion molecule for skin-homing memory T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1705666     DOI: 10.1038/349796a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  166 in total

Review 1.  T lymphocyte and fibroblast interactions: the case of skin involvement in systemic sclerosis and other examples.

Authors:  C Chizzolini
Journal:  Springer Semin Immunopathol       Date:  1999

2.  Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes.

Authors:  Eric J Kunkel; Judie Boisvert; Kristine Murphy; Mark A Vierra; Mark C Genovese; Andrew J Wardlaw; Harry B Greenberg; Martin R Hodge; Lijun Wu; Eugene C Butcher; James J Campbell
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

3.  Memory B lymphocytes from secondary lymphoid organs interact with E-selectin through a novel glycoprotein ligand.

Authors:  M C Montoya; K Holtmann; K R Snapp; E Borges; F Sánchez-Madrid; F W Luscinskas; G Kansas; D Vestweber; M O de Landázuri
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

4.  Skin- and gut-homing molecules on human circulating γδ T cells and their dysregulation in inflammatory bowel disease.

Authors:  E R Mann; N E McCarthy; S T C Peake; A N Milestone; H O Al-Hassi; D Bernardo; C T Tee; J Landy; M C Pitcher; S A Cochrane; A L Hart; A J Stagg; S C Knight
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

5.  Attenuation of colitis in the cotton-top tamarin by anti-alpha 4 integrin monoclonal antibody.

Authors:  D K Podolsky; R Lobb; N King; C D Benjamin; B Pepinsky; P Sehgal; M deBeaumont
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

6.  Interleukin 3 stimulates proliferation and triggers endothelial-leukocyte adhesion molecule 1 gene activation of human endothelial cells.

Authors:  M F Brizzi; G Garbarino; P R Rossi; G L Pagliardi; C Arduino; G C Avanzi; L Pegoraro
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

7.  Monocyte-endothelial adhesion in chronic rheumatoid arthritis. In situ detection of selectin and integrin-dependent interactions.

Authors:  J S Grober; B L Bowen; H Ebling; B Athey; C B Thompson; D A Fox; L M Stoolman
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

8.  Protective effects of sialylated oligosaccharides in immune complex-induced acute lung injury.

Authors:  M S Mulligan; J B Lowe; R D Larsen; J Paulson; Z L Zheng; S DeFrees; K Maemura; M Fukuda; P A Ward
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

9.  Higher-affinity oligosaccharide ligands for E-selectin.

Authors:  R M Nelson; S Dolich; A Aruffo; O Cecconi; M P Bevilacqua
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

10.  Expression of VCAM-1 and E-selectin in an in vivo model of endothelial activation.

Authors:  J W Fries; A J Williams; R C Atkins; W Newman; M F Lipscomb; T Collins
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.